Dare Bioscience, Inc. (DARE) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
8/25
Growth 2
Margin 1
Expansion 4
Platform 1
Financial 0
latest quarter score
Earnings Reports
- 8
- 12
- 10
- 9